Phase 3 Type 1 Diabetes Clinical Trials
8 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Type 1 Diabetes Mellitus
Sanofi723 enrolled107 locationsNCT07088068
Recruiting
Phase 3
Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
Type 1 Diabetes
Nanjing Medical University90 enrolled1 locationNCT07258394
Recruiting
Phase 3
GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
Type 1 Diabetes (T1D)
University of Bern42 enrolled3 locationsNCT06630585
Recruiting
Phase 3
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
Kidney TransplantType 1 Diabetes
Vertex Pharmaceuticals Incorporated10 enrolled7 locationsNCT06832410
Recruiting
Phase 2Phase 3
Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes
Type 1 DiabetesStem Cells
Ain Shams University20 enrolled1 locationNCT06951074
Recruiting
Phase 3
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Heart FailureCardiovascular DiseasesType 1 Diabetes+1 more
Steno Diabetes Center Copenhagen2,000 enrolled2 locationsNCT06082063
Recruiting
Phase 2Phase 3
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
Diabetes MellitusType 1 Diabetes
McGill University Health Centre/Research Institute of the McGill University Health Centre26 enrolled1 locationNCT06387199
Recruiting
Phase 2Phase 3
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
Type 1 Diabetes
Throne Biotechnologies Inc.50 enrolled2 locationsNCT04011020